Pursuing the goal to improve downstream myocardial tissue perfusion

European Heart Journal

Volumn 30, Issue 7, 2009, Pages 750-751

  Tamburino, Corrado ^a   Capodanno, Davide ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; FIBRINOGEN RECEPTOR; ISOSORBIDE DINITRATE; NICORANDIL; NITROPRUSSIDE SODIUM; PAPAVERINE; PLACEBO; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; TREATMENT OUTCOME; VASOCONSTRICTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; HUMANS; NICORANDIL; VASODILATOR AGENTS;

EID: 64849088868     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp065     Document Type: Editorial

References (4)

1. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
2. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002:105:656-662.
3. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. J Cardiol 1989;63:18-24.
4. Kawai Y, Hisamatsu K, Matsubara H, Dan K, Akagi S, Miyaji K, Munemasa M, Fujimoto Y, Kusano KF, Ohe T. Intravenous administration of nicorandil immediatetely before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J 2009;30:765-772. doi:10.1093/eurheartj/ehp077.